Click here to read the articles and view the interactive digital edition

Pharmaceutical Commerce - November 2025

Cencora executive Heather Zenk discusses how innovations in cold chain, data visibility, and sustainability strategies are transforming the drug delivery process.

Building Resilient, Sustainable Pharma Supply Chains

From patent cliffs and government price controls, to self-pay models and staff-model HMOs, a look at the forces that could deflate the bubble—and those factors likely to keep it afloat a while longer.

Popping the Gross-to-Net Bubble, Part VI: The Future of Pharmaceutical Pricing

Advice for pharma distributors and dispensers on what they should do now in order to solidify a secure supply chain.

DSCSA Compliance: Milestones, More Deadlines—and the Road Ahead

Articles

Pharma Pulse 5/20/25: Balancing Benefits, Risks, and Public Perception with HPV Vaccinations; Pfizer-Backed CellCentric Secures $120M for Further Myeloma Trials

. He can be reached at nsaraceno@mjhlifesciences.com.

The partnership is centered around cutting cold chain costs and emissions with smart packaging and carbon-neutral same-day delivery.

Invensify, Go2 Delivery Collaborate on Temperature-Controlled Courier Service

Videos

Ruth Beadle, head, global supply chain, Sanofi, discusses the company’s multi-year effort to build an AI-powered, end-to-end supply chain focused on improving service, resilience, and cost efficiency.

LogiPharma Europe 2025: Inside Sanofi’s Shift Toward a Data-Driven Supply Chain Model

Pharma Pulse 5/19/25: Navigating the Payer-Health System Nexus: A Strategic Imperative for Biopharma Commercial Success; Advocate for Change to Address Pharmacy Burnout

In an exclusive sit-down with Pharma Commerce, Anne Cassity, senior vice president of government affairs for the National Community Pharmacists Association (NCPA), discusses pending legislation that could affect the impact of PBM pricing. 

Limiting the Use of Spread Pricing

In the second part of his Pharma Commerce video interview, Kevin Dondarski, Deloitte’s life sciences R&D strategy leader, outlines strategies that companies can adopt to help mitigate these increasing costs.

How to Manage Rising Drug Development Costs

Pharma Pulse 5/16/25: A Closer Look at NIH Grant Terminations; Simulated Pre-Launch Market Evaluation in the Modern Pharmaceutical Industry

Ruth Beadle, head, global supply chain, Sanofi, explains how the company balances daily operations with long-term transformation efforts to ensure timely delivery of critical medications to patients.

LogiPharma Europe 2025: Inside the Daily Workflow of Sanofi’s Global Supply Chain Head

A qualitative study aimed to strengthen systematic repurposing efforts within rare disease nonprofit organizations, while also providing a framework for data-driven drug repurposing.

Themes Among Rare Disease Repurposing Efforts

Pharma Pulse 5/15/25: Five Questions on Trump’s Plan to Lower US Drug Prices; Roche Reports Final Overall Survival Outcomes from Breast Cancer Treatment Trial

Featured Content

Pharmaceutical Commerce - November 2025

Building Resilient, Sustainable Pharma Supply Chains

Popping the Gross-to-Net Bubble, Part VI: The Future of Pharmaceutical Pricing

DSCSA Compliance: Milestones, More Deadlines—and the Road Ahead